Azulfidine and Hyperglycemia - a phase IV clinical study of FDA data

Summary:

Hyperglycemia is reported as a side effect among people who take Azulfidine (sulfasalazine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Haloperidol, and have Oedema.

The phase IV clinical study analyzes which people have Hyperglycemia when taking Azulfidine. It is created by eHealthMe based on reports of 7,893 people who have side effects when taking Azulfidine from the FDA, and is updated regularly.

What is Azulfidine?

Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,997 Azulfidine users. Check the latest studies of Azulfidine.

What is Hyperglycemia?

Hyperglycemia (high blood sugar) is found to be associated with 1,656 drugs and 2,496 conditions by eHealthMe. Check the latest studies of Hyperglycemia.

On Jul, 10, 2026

7,893 people reported to have side effects when taking Azulfidine.
Among them, 12 people (0.15%) have Hyperglycemia.

Among these 12 people:

How long have people been on Azulfidine when they have Hyperglycemia? *

What is the gender of people who have Hyperglycemia when taking Azulfidine? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Hyperglycemia when taking Azulfidine? *

What are other drugs people take besides Azulfidine? *

What are other side effects people have besides Hyperglycemia? *

Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 25.00%
Oedema (fluid collection in tissue): 3 people, 25.00%
Hypokalemia (low potassium): 3 people, 25.00%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 3 people, 25.00%
Histiocytosis Haematophagic: 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Hypoglycemia (low blood sugar): 2 people, 16.67%
Fever: 1 person, 8.33%
Alanine Aminotransferase Increased: 1 person, 8.33%
Bacterial Infection: 1 person, 8.33%

What are the existing conditions these people have? *

Thrombocytopenia (decrease of platelets in blood): 3 people, 25.00%
Oedema (fluid collection in tissue): 3 people, 25.00%
Upper Respiratory Tract Infection: 2 people, 16.67%
Korsakoff's Syndrome (a mental illness involving severe confusion and inability to retain recent memories): 2 people, 16.67%
Hepatic Function Abnormal: 1 person, 8.33%
Haemostasis (stopping of bleeding): 1 person, 8.33%
Diabetes: 1 person, 8.33%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Azulfidine and have Hyperglycemia?

- Check whether Hyperglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azulfidine:

Azulfidine (7,997 reports)

Hyperglycemia treatments and more:

Hyperglycemia (48,691 reports)

Browse all side effects of Azulfidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperglycemia:

Hyperglycemia (1,656 drugs)

Browse all the conditions that are associated with Hyperglycemia:

Hyperglycemia (2,496 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Azulfidine) and Azulfidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.